Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Scientific Publications

Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans

Read more

Videos

A new approach to HIV vaccination

March 17, 2022

Watch this educational video to learn more about HIV bnAbs, sequential immunization, and IAVI's exciting new approach to HIV vaccine design. Broadly neutralizing antibodies, bnAbs for short, have the potential to neutralize or prevent infection with, many different HIV strains. IAVI’s goal is to design a series of sequential vaccine candidates that will prepare B cells to produce bnAbs before a person is exposed to HIV. These bnAbs could then protect the person from acquiring HIV if they were exposed to the virus in the future.  We are eager to continue our work developing a safe, effective HIV vaccine, which the world needs.

Read more

Features

HVTN 302 begins first dosing of mRNA HIV vaccine antigens

March 17, 2022

HVTN, NIAID, and Moderna partner on trial of HIV Env trimers designed by IAVI's William Schief.

Read more

Scientific Publications

Infection with HIV-1 subtype D among acutely infected Ugandans is associated with higher median concentration of cytokines compared to subtype A

Read more

Podcasts

Inside IAVI: Labs Worldwide

March 1, 2022

In this episode of Inside IAVI, Finora Franck, senior specialist, laboratory operations, sat down with some of our longest-serving laboratory colleagues to give a glimpse inside our global labs, and...
Read more

Scientific Publications

Antibiotic resistant and changes to the 2019 Rwandan National STI Guidelines

Read more

In The News

UK Lassa fever death highlights global threat of infectious diseases, experts say

The Guardian

February 18, 2022

Read more

Features

TB advocates call on Europe to fulfil commitments for new TB vaccines

February 17, 2022

New TB vaccines are our best hope for a world without TB — it’s time to step up and finally make them a reality.

Read more